Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 517 to 523 of 523 entries
Sorted by: Best Match Show Resources per page
Persistent Dark Cones in Oligocone Trichromacy Revealed by Multimodal Adaptive Optics Ophthalmoscopy.

Frontiers in aging neuroscience

Li J, Liu T, Flynn OJ, Turriff A, Liu Z, Ullah E, Liu J, Dubra A, Johnson MA, Brooks BP, Hufnagel RB, Hammer DX, Huryn LA, Jeffrey BG, Tam J.
PMID: 33767618
Front Aging Neurosci. 2021 Mar 09;13:629214. doi: 10.3389/fnagi.2021.629214. eCollection 2021.

Dark cone photoreceptors, defined as those with diminished or absent reflectivity when observed with adaptive optics (AO) ophthalmoscopy, are increasingly reported in retinal disorders. However, their structural and functional impact remain unclear. Here, we report a 3-year longitudinal study...

Cite
Li J, Liu T, Flynn OJ, et al. Persistent Dark Cones in Oligocone Trichromacy Revealed by Multimodal Adaptive Optics Ophthalmoscopy. Front Aging Neurosci. 2021;13:629214doi: 10.3389/fnagi.2021.629214.
Li, J., Liu, T., Flynn, O. J., Turriff, A., Liu, Z., Ullah, E., Liu, J., Dubra, A., Johnson, M. A., Brooks, B. P., Hufnagel, R. B., Hammer, D. X., Huryn, L. A., Jeffrey, B. G., & Tam, J. (2021). Persistent Dark Cones in Oligocone Trichromacy Revealed by Multimodal Adaptive Optics Ophthalmoscopy. Frontiers in aging neuroscience, 13629214. https://doi.org/10.3389/fnagi.2021.629214
Li, Joanne, et al. "Persistent Dark Cones in Oligocone Trichromacy Revealed by Multimodal Adaptive Optics Ophthalmoscopy." Frontiers in aging neuroscience vol. 13 (2021): 629214. doi: https://doi.org/10.3389/fnagi.2021.629214
Li J, Liu T, Flynn OJ, Turriff A, Liu Z, Ullah E, Liu J, Dubra A, Johnson MA, Brooks BP, Hufnagel RB, Hammer DX, Huryn LA, Jeffrey BG, Tam J. Persistent Dark Cones in Oligocone Trichromacy Revealed by Multimodal Adaptive Optics Ophthalmoscopy. Front Aging Neurosci. 2021 Mar 09;13:629214. doi: 10.3389/fnagi.2021.629214. eCollection 2021. PMID: 33767618; PMCID: PMC7985087.
Copy Download .nbib Format: NLM
Smartphone Thermal Imaging in the Detection of Testicular Ischemia.

Urology

Brooks JP, Brooks JM, Seals T.
PMID: 33689763
Urology. 2021 Mar 06; doi: 10.1016/j.urology.2021.02.031. Epub 2021 Mar 06.

OBJECTIVE: To evaluate smartphone thermal imaging as a point of care test in the detection of testicular ischemia. Thermal imaging detects the infrared (heat) pattern of an object and the technology is now available as an inexpensive attachment to...

Cite
Brooks JP, Brooks JM, Seals T. Smartphone Thermal Imaging in the Detection of Testicular Ischemia. Urology. 2021;doi: 10.1016/j.urology.2021.02.031.
Brooks, J. P., Brooks, J. M., & Seals, T. (2021). Smartphone Thermal Imaging in the Detection of Testicular Ischemia. Urology, . https://doi.org/10.1016/j.urology.2021.02.031
Brooks, J Patrick, et al. "Smartphone Thermal Imaging in the Detection of Testicular Ischemia." Urology vol. (2021). doi: https://doi.org/10.1016/j.urology.2021.02.031
Brooks JP, Brooks JM, Seals T. Smartphone Thermal Imaging in the Detection of Testicular Ischemia. Urology. 2021 Mar 06; doi: 10.1016/j.urology.2021.02.031. Epub 2021 Mar 06. PMID: 33689763.
Copy Download .nbib Format: NLM
Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19.

Muscle & nerve

Brooks BR, Pioro EP, Katz J, Takahashi F, Takei K, Zhang J, Apple S.
PMID: 34816454
Muscle Nerve. 2022 Feb;65(2):180-186. doi: 10.1002/mus.27467. Epub 2021 Dec 10.

INTRODUCTION: Phase 3 study MCI186-19 demonstrated less loss of physical function with edaravone versus placebo, as measured by the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) total score. A 1-point drop in an individual ALSFRS-R item may be...

Cite
Brooks BR, Pioro EP, Katz J, et al. Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19. Muscle Nerve. 2021;65(2):180-186doi: 10.1002/mus.27467.
Brooks, B. R., Pioro, E. P., Katz, J., Takahashi, F., Takei, K., Zhang, J., & Apple, S. (2022). Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19. Muscle & nerve, 65(2), 180-186. https://doi.org/10.1002/mus.27467
Brooks, Benjamin Rix, et al. "Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19." Muscle & nerve vol. 65,2 (2022): 180-186. doi: https://doi.org/10.1002/mus.27467
Brooks BR, Pioro EP, Katz J, Takahashi F, Takei K, Zhang J, Apple S. Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19. Muscle Nerve. 2022 Feb;65(2):180-186. doi: 10.1002/mus.27467. Epub 2021 Dec 10. PMID: 34816454.
Copy Download .nbib Format: NLM
Green Chemistry: A Framework for a Sustainable Future.

ACS omega

Ganesh KN, Zhang D, Miller SJ, Rossen K, Chirik PJ, Kozlowski MC, Zimmerman JB, Brooks BW, Savage PE, Allen DT, Voutchkova-Kostal AM.
PMID: 34235294
ACS Omega. 2021 Jun 15;6(25):16254-16258. doi: 10.1021/acsomega.1c03011. eCollection 2021 Jun 29.

No abstract available.

Cite
Ganesh KN, Zhang D, Miller SJ, et al. Green Chemistry: A Framework for a Sustainable Future. ACS Omega. 2021;6(25):16254-16258doi: 10.1021/acsomega.1c03011.
Ganesh, K. N., Zhang, D., Miller, S. J., Rossen, K., Chirik, P. J., Kozlowski, M. C., Zimmerman, J. B., Brooks, B. W., Savage, P. E., Allen, D. T., & Voutchkova-Kostal, A. M. (2021). Green Chemistry: A Framework for a Sustainable Future. ACS omega, 6(25), 16254-16258. https://doi.org/10.1021/acsomega.1c03011
Ganesh, Krishna N, et al. "Green Chemistry: A Framework for a Sustainable Future." ACS omega vol. 6,25 (2021): 16254-16258. doi: https://doi.org/10.1021/acsomega.1c03011
Ganesh KN, Zhang D, Miller SJ, Rossen K, Chirik PJ, Kozlowski MC, Zimmerman JB, Brooks BW, Savage PE, Allen DT, Voutchkova-Kostal AM. Green Chemistry: A Framework for a Sustainable Future. ACS Omega. 2021 Jun 15;6(25):16254-16258. doi: 10.1021/acsomega.1c03011. eCollection 2021 Jun 29. PMID: 34235294; PMCID: PMC8246463.
Copy Download .nbib Format: NLM
Disrupted cognitive development following pediatric acquired demyelinating syndromes: a longitudinal study.

Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence

De Somma E, O'Mahony J, Brown RA, Brooks BL, Yeh EA, Cardenas de La Parra A, Arnold D, Collins DL, Maranzano J, Narayanan S, Marrie RA, Bar-Or A, Banwell B, Till C.
PMID: 34872458
Child Neuropsychol. 2021 Dec 06;1-22. doi: 10.1080/09297049.2021.2002289. Epub 2021 Dec 06.

Long-term cognitive deficits have been observed in some children who experience an acquired demyelinating syndrome (ADS). We examined changes in cognitive functioning over the first two years following incident ADS andtested whether normalized brain and thalamic volume accounted for...

Cite
De Somma E, O'Mahony J, Brown RA, et al. Disrupted cognitive development following pediatric acquired demyelinating syndromes: a longitudinal study. Child Neuropsychol. 2021;1-22doi: 10.1080/09297049.2021.2002289.
De Somma, E., O'Mahony, J., Brown, R. A., Brooks, B. L., Yeh, E. A., Cardenas de La Parra, A., Arnold, D., Collins, D. L., Maranzano, J., Narayanan, S., Marrie, R. A., Bar-Or, A., Banwell, B., & Till, C. (2021). Disrupted cognitive development following pediatric acquired demyelinating syndromes: a longitudinal study. Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence, 1-22. https://doi.org/10.1080/09297049.2021.2002289
De Somma, Elisea, et al. "Disrupted cognitive development following pediatric acquired demyelinating syndromes: a longitudinal study." Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence vol. (2021): 1-22. doi: https://doi.org/10.1080/09297049.2021.2002289
De Somma E, O'Mahony J, Brown RA, Brooks BL, Yeh EA, Cardenas de La Parra A, Arnold D, Collins DL, Maranzano J, Narayanan S, Marrie RA, Bar-Or A, Banwell B, Till C. Disrupted cognitive development following pediatric acquired demyelinating syndromes: a longitudinal study. Child Neuropsychol. 2021 Dec 06;1-22. doi: 10.1080/09297049.2021.2002289. Epub 2021 Dec 06. PMID: 34872458.
Copy Download .nbib Format: NLM
Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design.

Neurology. Clinical practice

Berry J, Brooks B, Genge A, Heiman-Patterson T, Appel S, Benatar M, Bowser R, Cudkowicz M, Gooch C, Shefner J, Westra J, Agnese W, Merrill C, Nelson S, Apple S.
PMID: 34476128
Neurol Clin Pract. 2021 Aug;11(4):e472-e479. doi: 10.1212/CPJ.0000000000000968.

OBJECTIVES: To identify putative biomarkers that may serve as quantifiable, biological, nonclinical measures of the pharmacodynamic effect of edaravone in amyotrophic lateral sclerosis (ALS) and to report real-world treatment outcomes.METHODS: This is a prospective, observational, longitudinal, multicenter (up to...

Cite
Berry J, Brooks B, Genge A, et al. Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design. Neurol Clin Pract. 2021;11(4):e472-e479doi: 10.1212/CPJ.0000000000000968.
Berry, J., Brooks, B., Genge, A., Heiman-Patterson, T., Appel, S., Benatar, M., Bowser, R., Cudkowicz, M., Gooch, C., Shefner, J., Westra, J., Agnese, W., Merrill, C., Nelson, S., & Apple, S. (2021). Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design. Neurology. Clinical practice, 11(4), e472-e479. https://doi.org/10.1212/CPJ.0000000000000968
Berry, James, et al. "Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design." Neurology. Clinical practice vol. 11,4 (2021): e472-e479. doi: https://doi.org/10.1212/CPJ.0000000000000968
Berry J, Brooks B, Genge A, Heiman-Patterson T, Appel S, Benatar M, Bowser R, Cudkowicz M, Gooch C, Shefner J, Westra J, Agnese W, Merrill C, Nelson S, Apple S. Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design. Neurol Clin Pract. 2021 Aug;11(4):e472-e479. doi: 10.1212/CPJ.0000000000000968. PMID: 34476128; PMCID: PMC8382414.
Copy Download .nbib Format: NLM
Long-Term Functional Decline Following Vascular Surgery Among Vulnerable Adults.

Annals of vascular surgery

DeAngelo MM, Peacock JB, Holeman TA, Maloney M, Beckstrom J, Brooke BS.
PMID: 33895257
Ann Vasc Surg. 2021 Oct;76:87-94. doi: 10.1016/j.avsg.2021.04.002. Epub 2021 Apr 22.

BACKGROUND: Identification of high-risk patients that may experience functional decline following surgery poses a challenge to healthcare providers. The Vulnerable Elders Survey (VES-13) is a patient-reported tool designed to identify risk for health deterioration based on age, self-rated health,...

Cite
DeAngelo MM, Peacock JB, Holeman TA, et al. Long-Term Functional Decline Following Vascular Surgery Among Vulnerable Adults. Ann Vasc Surg. 2021;76:87-94doi: 10.1016/j.avsg.2021.04.002.
DeAngelo, M. M., Peacock, J. B., Holeman, T. A., Maloney, M., Beckstrom, J., & Brooke, B. S. (2021). Long-Term Functional Decline Following Vascular Surgery Among Vulnerable Adults. Annals of vascular surgery, 7687-94. https://doi.org/10.1016/j.avsg.2021.04.002
DeAngelo, Madeline M, et al. "Long-Term Functional Decline Following Vascular Surgery Among Vulnerable Adults." Annals of vascular surgery vol. 76 (2021): 87-94. doi: https://doi.org/10.1016/j.avsg.2021.04.002
DeAngelo MM, Peacock JB, Holeman TA, Maloney M, Beckstrom J, Brooke BS. Long-Term Functional Decline Following Vascular Surgery Among Vulnerable Adults. Ann Vasc Surg. 2021 Oct;76:87-94. doi: 10.1016/j.avsg.2021.04.002. Epub 2021 Apr 22. PMID: 33895257; PMCID: PMC8531166.
Copy Download .nbib Format: NLM
Showing 517 to 523 of 523 entries